CClinicalTrials.gg
TerminatedNCT04547582SCS-90Updated Jan 7, 2026Results posted

Spinal Cord Stimulation for Restoration of Function in Lower-Limb Amputees, 90-Day

An interventional study of Spinal cord stimulator in Traumatic Amputation of Lower Extremity and Phantom Limb Pain, sponsored by Lee Fisher, PhD. Terminated at 1 site in United States. Open to participants aged 22 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-01-07.

Sponsored by Lee Fisher, PhD · Not applicable, Interventional, and Treatment

Why this study was terminated
Additional participants were not enrolled after multiple years of recruitment efforts. Funding expired.
Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Not applicable
Ages
22 Years to 70 Years
Sex
All
01

Study summary

The goals of this study are to provide sensory information to amputees and reduce phantom limb pain via electrical stimulation of the lumbar spinal cord and spinal nerves. The spinal nerves convey sensory information from peripheral nerves to higher order centers in the brain. These structures still remain intact after amputation and electrical stimulation of the dorsal spinal nerves in individuals with intact limbs and amputees has been demonstrated to generate paresthetic sensory percepts referred to portions of the distal limb. Further, there is recent evidence that careful modulation of stimulation parameters can convert paresthetic sensations to more naturalistic ones when stimulating peripheral nerves in amputees. However, it is currently unclear whether it is possible to achieve this same conversion when stimulating the spinal nerves, and if those naturalistic sensations can have positive effects on phantom limb pain. As a first step towards those goals, in this study, the investigators will quantify the sensations generated by electrical stimulation of the spinal nerves, study the relationship between stimulation parameters and the quality of those sensations, measure changes in control of a prosthesis with sensory stimulation, and quantify the effects of that stimulation on the perception of the phantom limb and any associated pain.

Read the detailed description

During the study, FDA-cleared spinal cord stimulator leads will be placed in the lumbar epidural space of lower limb amputees and steered laterally towards the dorsal spinal roots under fluoroscopic guidance. This approach is essentially identical to the FDA-cleared procedure in which these devices are placed in the lumbar epidural space for treatment of intractable low back and leg pain. In that procedure, it is common clinical practice to place 2-3 leads temporarily in the epidural space through a percutaneous approach and perform a multiday trial to determine if the patient experiences any pain reduction from spinal cord stimulation. Following the trial, the percutaneous leads are surgically removed, and the patient is referred to a neurosurgeon for permanent surgical implantation.

Similarly, in this study, the device will be tunneled percutaneously through the skin and anchored in place. Using the stylet included with the spinal cord stimulator leads, the devices will be steered laterally under fluoroscopic guidance to target the dorsal spinal nerves. During lab experiments, the leads will be connected to an external stimulator. In this study, the devices will remain in the epidural space for up to 90 days and will be surgically removed. Throughout the study, the investigators will perform a series of psychophysical evaluations to characterize the sensory percepts evoked by epidural stimulation, along with functional evaluations of the effects of stimulation on the ability to control a prosthetic limb. In addition, the investigators will perform surveys to characterize changes in phantom limb sensation and pain that occur during stimulation.

02

Conditions studied

  • Traumatic Amputation of Lower Extremity
  • Phantom Limb Pain

Keywords

  • Phantom Limb Pain
  • Lower-Limb Amputation
  • electrodes
  • stimulation
  • BKA
  • pain
  • sensation
03

Who can participate

Ages eligible
22 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Subjects must have an amputation of one lower limb, at a level between the ankle and knee joints. Minor amputation of the contralateral limb (i.e. toes or partial foot) is not exclusionary.
  2. Subjects must be over 6 months post-amputation at the time of lead placement.
  3. Subjects must be between the ages of 22 and 70 years old. Participants outside this age range may be at an increased medical risk and have an increased risk of fatigue during testing.
  4. Subjects must have used their current prosthesis for at least 6 months and achieved at least K-1 ambulator status at the time of lead placement, as determined by the Amputee Mobility Predictor.

Exclusion criteria

Exclusion Criteria:

  1. Subjects must not have any serious disease or disorder that could affect their ability to participate in this study.
  2. Female subjects of childbearing age must not be pregnant or breast-feeding.
  3. Subjects must not be receiving medications that affect blood coagulation.
  4. Subjects must not have an allergy to contrast medium or renal failure that could be exacerbated by the contrast agent used in MRIs. For this study, renal insufficiency will be determined through blood work and defined as BUN of 30 or less and Creatinine of 1.5 or less.
  5. Subjects may not have a hemoglobin A1c level above 8.0 mg/dl at time of implant.
  6. Subjects may not have any implanted medical devices that are not cleared for MRI.
  7. Subjects with a T-Score higher than 63 on the 18-question Brief Symptoms Inventory (BSI-18) who have undergone discussions with and been deemed unsuitable by the Principal Investigator, a study physician, and a psychologist
  8. Subjects may not have a cardiac pacemaker.
  9. Subjects may not have a cardioverter defibrillator.
  10. Subjects may not be currently receiving diathermy therapy.
  11. Subjects may not have an implanted infusion pump.
  12. Subjects may not be immunosuppressed or currently receiving immunosuppressive medications.
  13. Subjects may not have a profession (e.g. radiology technologist) or medical condition (e.g. remissory cancer involved regular follow-up x-rays) that would increase radiation exposure in the 12 months prior to starting or after ending participation in the study.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
4 participants (actual)

Study arms

  • Experimental
    Spinal cord stimulation

    Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation. Participants in this study receive spinal cord stimulation will be trans-tibial amputees that are at least six month post--amputation. Subjects will have varying levels of phantom limb sensation and pain, but should have no other significant neurological disorders.

    Device: Spinal cord stimulator

Interventions

  • DeviceSpinal cord stimulator

    Spinal cord stimulator leads (2-3 leads) will be placed in the lumbar epidural space of lower limb amputees to determine if the patient experiences any pain reduction from spinal cord stimulation.

05

What researchers measure

Primary outcomes

  1. Number of Participants Experiencing Serious Device-related Adverse Events up to 90 Days Following Implantation

    Investigators will track the number of participants experiencing serious device-related adverse events, such as unresolved superficial infection resulting in lead removal, deep infection, inpatient hospitalization, withdrawal from the study due to worsening pain or intolerable dysesthesia, or fracture due to falls related to the study interventions, that occur during the course of and up to 90 days following implantation.

    Time frame: 90 days

  2. Minimum Amplitude of Pulse Required to Evoke Sensory Percepts

    Quantify the threshold stimulus required to evoke sensory percepts during epidural spinal nerve stimulation.

    Time frame: 90 days

  3. Minimum Charge Required to Evoke a Neurophysiological Response

    Quantify the threshold (minimum charge) stimulus required to evoke neurophysiological responses during epidural spinal nerve stimulation

    Time frame: 90 days

  4. Location of Evoked Sensation - Missing Toes

    Participants reporting sensation on missing toes from spinal cord stimulation.

    Time frame: 90 days

  5. Location of Evoked Sensation - Plantar Surface of Missing Foot

    Participants perceiving sensation on the plantar surface of missing foot

    Time frame: 90 days

Secondary outcomes

  1. Change in Phantom Limb Pain Using the McGill Pain Questionnaire

    The McGill Pain Questionnaire is a questionnaire used to evaluate the severity of pain experienced by the participant. The questionnaire is scaled, with a minimum and maximum pain score of 0 and 78, respectively. The higher the score on the questionnaire, the more intense the pain felt by the participant. A lower score than previously reported represents a decrease in experienced phantom limb pain. Before placement of the spinal cord stimulator leads, investigators will document the subject's description of their history of perceived phantom limb. Investigators will ask them to periodically update their perception of the limb throughout experimental sessions, as well as within a month after the device has been removed.

    Time frame: Pre-implant (baseline), Weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and post-explant (90 days)

  2. Qualitative Self-report of Evoked Sensations

    Document the subjective perception of lumbosacral epidural spinal nerve stimulation for restoration of sensation. The investigators will ask each subject to provide subjective feedback on their perceived utility of the sensory feedback provided by the device. A total of 13 natural descriptors and 5 paresthetic descriptors were presented to participants weekly to describe the sensation provided via spinal cord stimulation. The goal of the study is to elicit more natural than paresthetic descriptors from participants. Natural: pressure, tickle, flutter, warm, sharp, prick, cool, pulsing, vibration, itch, urge to move, touch, tap Parethetic: buzz, tingle, shock, electric current, numb

    Time frame: 90 days

  3. Able to Use a Prosthetic Limb With Neural Signals

    Investigators will test the subject's success rate during control of prosthetic limb with and without sensory feedback provided by electrical stimulation of the spinal roots. Using either a virtual prosthetic limb or an instrumented prosthesis, stimulation of the spinal roots will be modulated based on signals recorded from the limb.

    Time frame: 90 days

06

Results

Posted Jan 7, 2026

Participant flow

Subjects were enrolled from 2021 to 2023 from affiliated amputee clinics. Recruitment continued through 2025, but no additional subjects were enrolled.

Participant flow — Overall Study
MilestoneSpinal Cord Stimulation
Started1
Completed1
Not completed0

Outcome measures

PrimaryNumber of Participants Experiencing Serious Device-related Adverse Events up to 90 Days Following Implantation

Investigators will track the number of participants experiencing serious device-related adverse events, such as unresolved superficial infection resulting in lead removal, deep infection, inpatient hospitalization, withdrawal from the study due to worsening pain or intolerable dysesthesia, or fracture due to falls related to the study interventions, that occur during the course of and up to 90 days following implantation.

Time frame:
90 days
Reported as:
Count of participants · Participants
Number of Participants Experiencing Serious Device-related Adverse Events up to 90 Days Following Implantation
ParticipantsSpinal cord stimulation
Number of Participants Experiencing Serious Device-related Adverse Events up to 90 Days Following Implantation0
PrimaryMinimum Amplitude of Pulse Required to Evoke Sensory Percepts

Quantify the threshold stimulus required to evoke sensory percepts during epidural spinal nerve stimulation.

Time frame:
90 days
Reported as:
Number · milliamps
Minimum Amplitude of Pulse Required to Evoke Sensory Percepts
milliampsSpinal Cord Stimulation
Minimum Amplitude of Pulse Required to Evoke Sensory Percepts2
PrimaryMinimum Charge Required to Evoke a Neurophysiological Response

Quantify the threshold (minimum charge) stimulus required to evoke neurophysiological responses during epidural spinal nerve stimulation

Time frame:
90 days
Reported as:
Number · uC (microcoulombs)
Minimum Charge Required to Evoke a Neurophysiological Response
uC (microcoulombs)Spinal cord stimulation
Minimum Charge Required to Evoke a Neurophysiological Response1.23
PrimaryLocation of Evoked Sensation - Missing Toes

Participants reporting sensation on missing toes from spinal cord stimulation.

Time frame:
90 days
Reported as:
Count of participants · Participants
Location of Evoked Sensation - Missing Toes
ParticipantsSpinal Cord Stimulation
Location of Evoked Sensation - Missing Toes1
PrimaryLocation of Evoked Sensation - Plantar Surface of Missing Foot

Participants perceiving sensation on the plantar surface of missing foot

Time frame:
90 days
Reported as:
Count of participants · Participants
Location of Evoked Sensation - Plantar Surface of Missing Foot
ParticipantsSpinal Cord Stimulation
Location of Evoked Sensation - Plantar Surface of Missing Foot1
SecondaryChange in Phantom Limb Pain Using the McGill Pain Questionnaire

The McGill Pain Questionnaire is a questionnaire used to evaluate the severity of pain experienced by the participant. The questionnaire is scaled, with a minimum and maximum pain score of 0 and 78, respectively. The higher the score on the questionnaire, the more intense the pain felt by the participant. A lower score than previously reported represents a decrease in experienced phantom limb pain. Before placement of the spinal cord stimulator leads, investigators will document the subject's description of their history of perceived phantom limb. Investigators will ask them to periodically update their perception of the limb throughout experimental sessions, as well as within a month after the device has been removed.

Time frame:
Pre-implant (baseline), Weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and post-explant (90 days)
Reported as:
Number · score on a scale
Change in Phantom Limb Pain Using the McGill Pain Questionnaire
score on a scaleSpinal Cord Stimulation
Pre-implant (baseline)48
Week 1 (after implant)32
Week 245
Week 345
Week 423
Week 538
Week 632
Week 734
Week 817
Week 946
Week 1041
Week 1165
Post-explant (90 days)47
SecondaryQualitative Self-report of Evoked Sensations

Document the subjective perception of lumbosacral epidural spinal nerve stimulation for restoration of sensation. The investigators will ask each subject to provide subjective feedback on their perceived utility of the sensory feedback provided by the device. A total of 13 natural descriptors and 5 paresthetic descriptors were presented to participants weekly to describe the sensation provided via spinal cord stimulation. The goal of the study is to elicit more natural than paresthetic descriptors from participants. Natural: pressure, tickle, flutter, warm, sharp, prick, cool, pulsing, vibration, itch, urge to move, touch, tap Parethetic: buzz, tingle, shock, electric current, numb

Time frame:
90 days
Reported as:
Count of participants · Participants
Qualitative Self-report of Evoked Sensations
ParticipantsSpinal Cord Stimulation
More natural than paresthetic descriptors.1
More paresthetic than natural descriptors.0
SecondaryAble to Use a Prosthetic Limb With Neural Signals

Investigators will test the subject's success rate during control of prosthetic limb with and without sensory feedback provided by electrical stimulation of the spinal roots. Using either a virtual prosthetic limb or an instrumented prosthesis, stimulation of the spinal roots will be modulated based on signals recorded from the limb.

Time frame:
90 days
Reported as:
Count of participants · Participants
Able to Use a Prosthetic Limb With Neural Signals
ParticipantsSpinal Cord Stimulation
Able to Use a Prosthetic Limb With Neural Signals1

Adverse events

Collected over 90 days. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Spinal Cord Stimulation0/1 (0%)0/1 (0%)1/1 (100%)
Most frequent other events
Most frequent other events
EventSpinal Cord Stimulation
Incision painSurgical and medical procedures1/1
Chest pain after surgerySurgical and medical procedures1/1

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Spinal Cord Stimulation
<=18 years0
Between 18 and 65 years1
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Spinal Cord Stimulation
Female1
Male0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Spinal Cord Stimulation
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American0
White1
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Spinal Cord Stimulation
United States1
07

Study locations

1 site
  • University of Pittsburgh
    Pittsburgh, Pennsylvania 15213, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Oct 15, 2025
  • Informed consent form · Apr 15, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — The investigators may share data with researchers at other centers for the purpose of data analysis and collaboration.

Supporting information: Sap, Icf

09

Registry details

Key details

Study ID
NCT04547582
Lead sponsor
Lee Fisher, PhD
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Responsible party
Lee Fisher, PhD (Assistant Professor, University of Pittsburgh) — Sponsor-investigator
First posted
Sep 14, 2020
Start date
May 27, 2021
Primary completion
Jul 3, 2023
Completion
Jul 3, 2023
Results posted
Jan 7, 2026
Last update
Jan 7, 2026

Study contacts

Lee E Fisher, PhD
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion